References
- Jiang, X. F.; Zhen, Y. S. Acta Pharm. Sin. 1999, 34, 164
- Wang, X. H.; Zhen, Y. S. Chin J. Cancer. 2001, 20, 789
- Huang, Q.; Shen, H. M.; Ong, C. N. Biochemical Pharmacology 2004, 68, 361 https://doi.org/10.1016/j.bcp.2004.03.032
- Fang, J.; Shing, Y.; Wiederschain, D. Proc. Natl. Acad. Sci. USA 2000, 97, 3884 https://doi.org/10.1073/pnas.97.8.3884
- Li, Y. L.; Xu, W. F. Bioorg. Med. Chem. 2004, 12, 5171 https://doi.org/10.1016/j.bmc.2004.07.025
- Wei, B.; Wu, S. H.; Chung, M. Eur. J. Med. Chem. 2000, 35, 1089 https://doi.org/10.1016/S0223-5234(00)01190-9
Cited by
- 6-[3-(2,4-Dimethylanilino)-2-hydroxypropoxy]-1,8-dihydroxy-3-methyl-9,10-dihydroanthracene-9,10-dione vol.65, pp.2, 2009, https://doi.org/10.1107/S1600536809002347
- Facile Synthesis of Emodin Derivatives as Potential MMPIs. vol.37, pp.16, 2006, https://doi.org/10.1002/chin.200616209